SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-030606
Filing Date
2012-05-18
Accepted
2012-05-18 15:47:13
Documents
9
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v313755_10q.htm 10-Q 347887
2 EXHIBIT 31.1 v313755_ex31-1.htm EX-31.1 9409
3 EXHIBIT 32.1 v313755_ex32-1.htm EX-32.1 5688
  Complete submission text file 0001144204-12-030606.txt   2079942

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ctix-20120331.xml EX-101.INS 253484
5 XBRL TAXONOMY EXTENSION SCHEMA ctix-20120331.xsd EX-101.SCH 20591
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctix-20120331_cal.xml EX-101.CAL 30796
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctix-20120331_def.xml EX-101.DEF 114933
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctix-20120331_lab.xml EX-101.LAB 157346
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctix-20120331_pre.xml EX-101.PRE 135296
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 (978)-633-3623
Cellceutix CORP (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-52321 | Film No.: 12855418
SIC: 2834 Pharmaceutical Preparations